Enabling happier and healthier lives.
Vision
Despite significant advances in medicine, millions of people continue to suffer without adequate treatment.
Our vision is to harness the power of AI and event-driven pharmacology to design and discover ground-breaking medicines for these formidable illnesses.
We imagine a future where no disease goes untreated, bringing hope and healing to those in need.
Mission
Our mission is to pioneer the next generation of drug discovery through the application of AI-driven design of molecular glues for undrugged disease-causing proteins.
Driven by People and Passion.
Leadership
Jakob Hohenberger 
CEO and Board Director
Dr. Chris Tame
CSO
Dr. Rosa Cookson
Head of Chemical Biology
Dr. Andrew Potterton
Head of Technology Platform
Dr. Adam Yip
Head of Exploratory
Dr. Dominykas Lukauskis
Software Engineer
Board of Directors and Advisory
Dr. Peter Ho
Board Director
Karel Kubias
Board Director
Marius Swart
Board Director
Dr. John Harling
Chair of the Sc. Advisory Board
Former Senior Sc. Director at GSK
